BioNTech SE is 18.7x more valuable than Immatics N.V. by market capitalization ($22.18 B vs $1.19 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IMTX | BNTX |
|---|---|---|
| Market cap | $1.19 B | $22.18 B |
| US-listed rank | #2509 | #582 |
| SEC filings | 220 | 548 |
BioNTech SE is 18.7x more valuable than Immatics N.V. by market capitalization ($22.18 B vs $1.19 B).
Full pages: Immatics N.V. and BioNTech SE, or browse the full rankings.